|Articles|September 1, 2016
- BioPharm International-09-01-2016
- Volume 29
- Issue 9
BioPharm International, September 2016 Issue (PDF)
Click the title above to open the BioPharm International September 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 9 years ago
Parenteral Advisory: Outmoded Fill/Finish Technologyover 9 years ago
Analyzer Automates Cell-Culture Chemistry Analysisover 9 years ago
Data Logger Provides Ultra-Low Temperature Readingsover 9 years ago
Manufacturing and Distribution Boundaries Blurover 9 years ago
Modeling Bioreactor Performanceover 9 years ago
Implementing a Dual Approach to Protein Characterizationover 9 years ago
Efforts Accelerate to Streamline Postapproval Change ProcessNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
3
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
4
Industry Outlook 2026: Key Forces Transforming Drug Pipelines (Part 2)
5
